Table 1 Characteristics of patients undergoing lobectomy
Variables | VATS (n = 112) | THORAC (n = 112) | P value |
|---|---|---|---|
Clinical data | |||
Age (mean ± SD, years) | 71 ± 8 | 71 ± 6 | 0.95 |
Male (%) | 71 (63.4) | 69 (61.7) | 0.79 |
Smoking (%) | 67 (59.8) | 65 (58.0) | 0.75 |
Hypertension (%) | 35 (31.3) | 32 (28.5) | 0.78 |
CAD (%) | 18 (16.1) | 16 (14.3) | 0.81 |
β-blockage | 16 (14.2) | 15 (13.4) | 0.61 |
Diabetes (%) | 12 (10.7) | 10 (8.9) | 0.67 |
Chemotherapy (%) | 16 (14.3) | 13 (11.6) | 0.59 |
Heart rate (beats/min) | 70 ± 12 | 72 ± 13 | 0.89 |
Pulmonary function | |||
FVC (%) | 90 ± 27 | 97 ± 22 | 0.56 |
FEV1 (%) | 86 ± 22 | 85 ± 20 | 0.63 |
Surgical procedure | |||
Right lobectomy (%) | 47 (42) | 45 (40.2) | 0.82 |
Left lobectomy (%) | 65 (58) | 67 (59.8) | 0.72 |
Pathology (%) | |||
Adenocarcinoma | 52 (46.4) | 48 (42.8) | 0.58 |
Squamous carcinoma | 49 (43.7) | 52 (46.4) | 0.42 |
Small cell lung carcinoma | 6 (5.4) | 5 (4.5) | 0.32 |
Large cell lung carcinoma | 5 (4.5) | 7 (6.3) | 0.28 |
Postoperative complication | |||
Atrial fibrillation (%) | 19 (16.9) | 20 (17.9) | 0.79 |
Pneumonia (%) | 2 (1.7) | 3 (2.6) | 0.73 |
Atelectasis (%) | 6 (5.2) | 8 (7.1) | 0.61 |
Air leak duration (%) | 14 (12.5) | 12 (12.7) | 0.71 |
Length of stay in hospital (days) | 7.5 ± 3.2 | 13.6 ± 4.1 | < 0.005 |